New pill tested to slow scarring lung disease
Disease control
Completed
This study tested a new oral medication called TTI-101 for people with idiopathic pulmonary fibrosis (IPF), a disease that causes permanent scarring in the lungs. For 12 weeks, 100 participants took either the drug or a placebo pill to see how safe it was and how their bodies pro…
Phase: PHASE2 • Sponsor: Tvardi Therapeutics, Incorporated • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC